Please login to the form below

Not currently logged in

Ventana MMR RxDx Panel

This page shows the latest Ventana MMR RxDx Panel news and features for those working in and with pharma, biotech and healthcare.

FDA approval for Roche diagnostic solid tumour test

FDA approval for Roche diagnostic solid tumour test

Test will identify which patients could benefit from GSK immunotherapy. The US Food and Drug Administration (FDA) has approved Roche’s Ventana MMR RxDx Panel, a companion diagnostic test designed to ... The Roche test evaluates a panel of MMR proteins

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts


Add my company
Origins - The Patient Focused Specialists

Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value...

Latest intelligence

Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...